LEP and hepatocellular carcinoma: Administration of leptin to pancreatic cancer cell lines activates STAT3 signaling [13], whereas adiponectin inhibits leptin induced phosphorylation of STAT3 in prostate, esophageal and hepatocellular carcinoma cells [18, 19].